OJ, Thank you for your reply. You certainly ha
Post# of 36566
(Total Views: 394)
Posted On: 10/10/2020 1:36:42 PM
Re: OrlandoJohn #22441
OJ,
Thank you for your reply. You certainly have my empathy and compassion in that regard, and you will see $10 IMO as that hopefully will happen within the next 6-9 months, or hopefully sooner!
I agree that once the peptides are confirmed that is the most optically obvious point at which the pps will rise. If we take a step back and look at the challenges GNBT has overcome, if they were to have failed, they would have by now. To engage in positive momentum and do all what they have done in development of a vaccine is astonishing without real funds...and yet they still have guided us to this point. Moreover, GNBT has sustained continuous development in its other company areas as well during this time, so they are honoring their wider/longer vision while adapting to the changing market conditions. What may look like chasing the moment is actually them fitting the greater puzzle pieces together. I haven’t even recognized the headache that trying to deal with an SEC audit during this time must have provided challenge around every corner. Again, if GNBT were to fail, they would have during the last 6-12 months...and they did not.
Now comes the fun part...funding is solid, paid-for development track, commercialization licensing deals in multiple countries. Uplisting with roadshow coming soon.
Frankly it is very impressive how GNBT/NGIO have been able to execute despite no support from BARDA or anywhere else. Joe and team are first and goal at the 3 yard line. Just need to punch it through!!
Thank you for your reply. You certainly have my empathy and compassion in that regard, and you will see $10 IMO as that hopefully will happen within the next 6-9 months, or hopefully sooner!
I agree that once the peptides are confirmed that is the most optically obvious point at which the pps will rise. If we take a step back and look at the challenges GNBT has overcome, if they were to have failed, they would have by now. To engage in positive momentum and do all what they have done in development of a vaccine is astonishing without real funds...and yet they still have guided us to this point. Moreover, GNBT has sustained continuous development in its other company areas as well during this time, so they are honoring their wider/longer vision while adapting to the changing market conditions. What may look like chasing the moment is actually them fitting the greater puzzle pieces together. I haven’t even recognized the headache that trying to deal with an SEC audit during this time must have provided challenge around every corner. Again, if GNBT were to fail, they would have during the last 6-12 months...and they did not.
Now comes the fun part...funding is solid, paid-for development track, commercialization licensing deals in multiple countries. Uplisting with roadshow coming soon.
Frankly it is very impressive how GNBT/NGIO have been able to execute despite no support from BARDA or anywhere else. Joe and team are first and goal at the 3 yard line. Just need to punch it through!!
(9)
(0)